Pathology: mNSCLC - L2 - all population;
mNSCLC - L2 - all population | ||||||
OAK (all population), 2016 | POPLAR, 2016 | JAVELIN Lung 200 (all population), 2018 | CheckMate 078, 2019 | RATIONALE 303, 0 | ||
atezolizumab alone | 2 | T1 | T1 | |||
Tislelizumab | 1 | T1 | ||||
nivolumab alone | 1 | T1 | ||||
avelumab alone | 1 | T1 | ||||
docetaxel | 0 | T0 | T0 | T0 | T0 | T0 |